ClinicalTrials.gg
Sign In
Drug

Deutetrabenazine clinical trials

Also written Austedo and SD-809.

studies test it
13
open now
1
in phase 3
7
first study started
2013

How each study uses deutetrabenazine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the deutetrabenazine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
3 Apr 2017 · AUSTEDO · NDA 208082 (FDA, Drugs@FDA)
European Union
8 Jan 2026 · Austedo · EMEA/H/C/006371 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Deutetrabenazine
7
Deutetrabenazine Oral Tablet [Austedo]
2

Brand

Austedo
6

Development codes

SD-809
6
TEV-50717
1

Studies by the year they started

13 studies that test it; most in 2014 (4)

Studies that test deutetrabenazine, by start year
YearStudies
20132
20144
20181
20201
20212
20221
20241
20261

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
4
Phase 3
7
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Huntington Disease
6
Tardive Dyskinesia
4
Tourette Syndrome
2
Dystonic Disorders
1

Who runs them

Industry 8 · Other 5

Auspex Pharmaceuticals, Inc. (5) · Teva Branded Pharmaceutical Products R&D, Inc. (2) · Vanderbilt University Medical Center (1) · Teva Branded Pharmaceutical Products R&D LLC (1) · University of Pennsylvania (1) · University Hospitals Cleveland Medical Center (1) · Fundacion Huntington Puerto Rico (1) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

Often tested with

Tested in the same studies.

Haloperidol (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test deutetrabenazine, phase 3 first.

Studies

Open first, then newest update. How each study uses deutetrabenazine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Codes

What other systems call deutetrabenazine · ClinicalTrials.gg INT000511

  • MeSH (NLM) C000609690deutetrabenazineConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) P341G6W9NBDEUTETRABENAZINEConfirmed FDA, NLM, Wikidata
  • RxNorm 1876905One source FDA
  • Wikidata Q27077026deutetrabenazineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C174828DeutetrabenazineOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.